Effect of troglitazone on leptin production: Studies in vitro and in human subjects

Diabetes

Volumn 45, Issue 9, 1996, Pages 1276-1278

  Nolan, John J ^a,b   Olefsky, Jerrold M ^a   Nyce, Mark R ^c   Considine, Robert V ^c   Caro, Jose F ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ST JAMES S HOSPITAL   (Ireland)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; TROGLITAZONE;

ADIPOCYTE; ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GENE MUTATION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

EID: 0029795431     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.9.1276     Document Type: Article

References (16)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
2. Campfleld LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neuronal networks. Science 269:546-549, 1995
3. Considine RV, Considine EL, Williams CJ, Nyce MR, Magosin S, Bauer TL, Rosato RL, Colberg J, Caro JF: Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 95:2986-2988, 1995
4. Consididine RV, Sinha MK, Heiman ML, Kriaugiunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996
5. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry KR, Mudaliar SR, Olefsky JM, Caro JF: Acute and chronic effect of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 45:699-701, 1996
6. Iwamoto Y, Kuzuya T, Matsuda A, Awata T, Kumakura S, Inooka G, Shiraishi I: Effects of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM. Diabetes Care 14:1083-1086, 1991
7. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H: Characterization of new oral antidiabetic agent CS-045: studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 37:1549-1558, 1988
8. Ciaraldi TP, Gilmore A, Olefsky JM, Goldberg M, Heidenreich KA: In vitro studies on the action of CS-045, a new antidiabetic agent. Metabolism 39:1056-1062, 1990
9. Suter SL, Nolan JJ, Wallace P, Gumbiner RW, Olefsky JM: Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care 15:193-203, 1992
10. Nolan JJ, Ludvik BL, Beerdsen P, Joyce M, Olefsky JM: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331:1188-1193, 1994
11. 2 is a ligand for the adipocyte determination factor PPARv. Cell 83:803-812, 1995
12. Tontonoz P, Graves RA, Budavari AI, Erdjument-Bromage H, Lui M, Hu E, Tempst P, Spiegelman BM: Adipocyte-speciflc transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha. Nucleic Acids Res 22:5628-5634, 1994
13. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM: mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8:1224-1234, 1994
14. Ohsumi J, Sakakibara S, Yamaguchi J, Miyadai K, Yoshioka S, Fujiwara T, Horikoshi H, Serizawa N: Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells. Endocrinology 135:2279-2282, 1994
15. Szalkowski D, White-Carrington S, Berger J, Zhang B: Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology 136:1474-1481, 1995
16. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group, Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)